ARVN - Jefferies upgrades Arvinas to buy in wake of positive ARV-471 data
2023-12-06 14:00:43 ET
More on Arvinas
- Arvinas: Protein Degradation Pioneer Presents An Intriguing Speculative Buy Opportunity
- Arvinas stock jumps 30% amid positive data for breast cancer drug
- Arvinas announces private placement to raise $350M
- Seeking Alpha’s Quant Rating on Arvinas
- Historical earnings data for Arvinas
For further details see:
Jefferies upgrades Arvinas to buy in wake of positive ARV-471 data